Value Bridge — CIVISTA MEDICAL CENTER
Current $5M → Target $8M (+$3.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$4.5M
Current EBITDA
$7.9M
Target EBITDA
+$3.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.8M
Payer Mix Optimization
$1.9M
Cost to Collect Reduction
$0.6M
Clean Claim Improvement
$0.5M
Volume & Rate Growth
$3.1M
What This Means
The 7-lever model projects a 76% EBITDA uplift from $5M to $8M. The highest-impact lever is Volume & Rate Growth at $1.2M probability-weighted.
IC talking point: "We see $3M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $38M in equity value creation."